Imaging Techniques for Glaucoma
(FSOCT Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to develop and test advanced imaging tools for early glaucoma detection. Researchers are creating new methods to examine the eye's structure and blood flow using special imaging techniques. The trial seeks to predict how glaucoma might begin or progress over time. Individuals with normal eye health or early signs of glaucoma, such as optic nerve changes or visual field issues, may be suitable for this study. As an unphased trial, it offers participants the chance to contribute to groundbreaking research that could lead to earlier detection and improved management of glaucoma.
Will I have to stop taking my current medications?
The trial does not specify if you need to stop taking your current medications, but you cannot participate if you use chronic ocular or systemic corticosteroids.
Why are researchers excited about this trial?
Researchers are excited about the trial on functional and structural imaging for glaucoma because it could revolutionize how we diagnose and monitor this eye condition. Unlike current treatments that focus on lowering eye pressure through medications or surgery, this approach aims to enhance our understanding of glaucoma by providing detailed images of the eye's structure and function. This could lead to earlier detection and more personalized treatment plans, potentially improving outcomes for patients.
Who Is on the Research Team?
Aiyin Chen, MD
Principal Investigator
Oregon Health and Science University
Are You a Good Fit for This Trial?
Inclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Imaging Development
Development and validation of high-resolution OCT and OCT angiography prototypes to improve imaging of structure and perfusion
Data Collection and Analysis
Collection of data using developed OCT methods to simulate visual field results and assess glaucoma detection, conversion, and progression
Follow-up
Participants are monitored for safety and effectiveness after imaging and data collection
What Are the Treatments Tested in This Trial?
Interventions
- None
Find a Clinic Near You
Who Is Running the Clinical Trial?
Oregon Health and Science University
Lead Sponsor
National Eye Institute (NEI)
Collaborator